---
title: "Meril Italy S.r.l. v SWAT Medical AB and another (UPC CoA 634/2024, 12-02-2025)"
description: "A lawyer or European Patent Attorney who is personally a party before the UPC cannot represent themselves."
url: https://pitch.law/academy/upc-court-of-appeal/upc-coa-634-2024-2025-02-12
lang: en
author: "UPC Case Law by Pitch"
editor: "Bart Lieben"
datePublished: 2026-11-18T10:07:18.905Z
dateModified: 2026-11-18T10:07:18.905Z
---

# Meril Italy S.r.l. v SWAT Medical AB and another

Order of the UPC Court of Appeal of 12 February 2025, UPC CoA 634/2024.

UPC Case Law by Pitch, edited by [Bart Lieben](https://pitch.law/team/bart-lieben) · Published 18-11-2026

## TL;DR

A lawyer or European Patent Attorney who is personally a party before the UPC cannot represent themselves. A company cannot be represented by the chair of its board, even one qualified to act before the UPC. The Court of Appeal raised representation of its own motion, but exceptionally gave the applicants for register access 14 days to appoint proper representatives and lodge a Statement of response.

## Key holding

Under R 8.1 RoP and Art 48 UPCA, lawyers and European Patent Attorneys are not exempted from the duty to be represented if they themselves are parties in cases before the UPC. A natural person with extensive administrative and financial powers in a legal person, such as the chair of its board of directors, cannot represent that legal person, whatever their UPC qualification. Representation is a point of admissibility involving public policy (due process) which the Court may examine at any time, of its own motion.

## Questions decided

1. May a European Patent Attorney who is a party represent himself before the UPC?
2. May the chair of a company's board represent that company before the UPC?
3. Is an inadmissibility objection first raised after the grounds of appeal admissible?
4. May the Court examine representation of its own motion at any time?
5. When will the Court allow a party time to appoint a representative?

## Case details

- Court: Court of Appeal of the Unified Patent Court, Second Panel
- Panel: Rian Kalden (presiding judge and legally qualified judge); Ingeborg Simonsson (legally qualified judge and judge-rapporteur); Patricia Rombach (legally qualified judge)
- Date: 12-02-2025
- Case number(s): UPC CoA 634/2024, UPC CFI 255/2024, UPC CFI 255/2023
- Parties: Appellant: Meril Italy S.r.l. (claimant in the main revocation proceedings and respondent to the access application at first instance); Respondents: Respondent 1 (name not stated in the published order) and SWAT Medical AB (applicants for access at first instance)
- Language of the proceedings: English
- Outcome: The Court of Appeal ordered Respondent 1 and SWAT Medical AB each to instruct an authorised representative under R 8.1 RoP within 14 days from service of the order.
- Official text on the court’s website (PDF): https://www.unified-patent-court.org/sites/default/files/files/api_order/36EC392377749B17102AFEDB235EEBD9_en.pdf

## How to cite

Court of Appeal, Meril Italy S.r.l. v SWAT Medical AB and another, UPC CoA 634/2024, Order of 12 February 2025 (OSCOLA)

## Full summary

Read the full analyses for free — create a free account: https://pitch.law/academy/upc-court-of-appeal/upc-coa-634-2024-2025-02-12

Topics: [Procedure](https://pitch.law/academy/upc-court-of-appeal/topics/procedure)

## In the same case

- [Meril Italy Srl and others v Edwards Lifesciences Corporation, UPC CoA 464/2024, 25-11-2025](https://pitch.law/academy/upc-court-of-appeal/upc-coa-464-2024-2025-11-25): The Court of Appeal upheld EP 3 646 825 as amended by Auxiliary Request II and confirmed that Meril's Myval Octacor heart valve system infringes it.
- [Meril GmbH and others v Edwards Lifesciences Corporation, UPC CoA 166/2025, 18-04-2025](https://pitch.law/academy/upc-court-of-appeal/upc-coa-166-2025-2025-04-18): The Court of Appeal refused Meril's request to suspend the Munich Local Division's infringement decision in favour of Edwards Lifesciences pending Meril's appeal.

## More on procedure

- [PAUSTIAN & PARTNER Patentanwälte mbB v NUC Electronics Europe GmbH and others, UPC CoA 163/2026, 11-11-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-163-2026-2026-11-11): The Court of Appeal granted a patent law firm access to the statements of appeal and statements of grounds of appeal in three closed appeals concerning EP 2 028 981.
- [The Walt Disney Company and others v InterDigital VC Holdings, Inc., UPC CoA 133/2026, 05-11-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-133-2026-2026-11-05): A request under R 262A RoP to stop the other party from accessing or using confidential information cannot be made for the first time on appeal for material already filed at first instance.
- [Guardant Health, Inc. v Sophia Genetics SA and others, UPC CoA 49/2026, 05-11-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-49-2026-2026-11-05): The Court of Appeal set aside a EUR 600,000 award of representation costs because the successful party had backed it only with invoices reading "supply of legal services" and general assertions about complexity and urgency.
- [Netflix Services Germany GmbH and others v DivX, LLC, UPC CoA 176/2026, 02-11-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-176-2026-2026-11-02): The Court of Appeal refused Netflix's request for suspensive effect against the Munich Local Division's infringement decision in favour of DivX, even though the EPO Opposition Division revoked the patent after that decision.
